fb-pixel Skip to main content
Health and biotech

Latest stories

More biotech and health care stories

Cambridge biotech wins approval for much-debated ALS drug

The closely watched drug, called Relyvrio, was developed by Amylyx Pharmaceuticals, a biotech founded in 2013 by two Brown University graduates.

Pfizer seeks to expand omicron booster to 5- to 11-year-olds

Elementary school-aged children already received kid-sized doses of Pfizer’s original vaccine, a third of the dose given to everyone 12 and older.

Annoying, yes, but will they also make you sick? UMass professor calls for more study of risk from houseflies

A University of Massachusetts Amherst professor is arguing that more attention needs to be paid to “synanthropic” flies — the non-biting flies that live alongside us — as potential disease carriers.

Can a nutritious daily shake stave off memory loss? A new trial aims to answer that, and is seeking volunteers.

Tufts University researchers are testing whether a specially-designed, daily nutritious shake for adults over age 55 can help stave off memory loss and control weight.

Ventus Therapeutics cuts $70m deal with Danish drug giant Novo Nordisk

The small local biotech is working on drugs to treat conditions like nonalcoholic fatty liver disease and chronic kidney disease.

Promising Alzheimer’s drug provides second chance for Biogen, and a debated theory about the disease

Like other available treatments, lecanemab does not cure, reverse, or even halt the memory-robbing disease — but it adds new information to the long-running debate about the cause of Alzheimer’s disease and how best to treat it.

New five-year MassHealth agreement will improve homeless insurance coverage, hospital funding

The state has signed a new $67 billion five-year agreement with the federal government on a number of reforms for Medicaid, an approval that will increase federal money to Massachusetts hospitals and fuel changes in how the state’s Medicaid program insures the homeless.

Staffing shortages keep one-fifth of psychiatric beds out of commission

Hundreds more beds could be used if there were enough workers to staff them.